SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+32.15%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$901M
AUM Growth
+$901M
(-9.2%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-27.47%
Top 10 Holdings %
Top 10 Hldgs %
45.07%
Holding
107
New
16
Increased
16
Reduced
34
Closed
33
Top Buys
| 1 |
HCA Healthcare
HCA
|
$27.5M |
| 2 |
IDEAYA Biosciences
IDYA
|
$20.1M |
| 3 |
Penumbra
PEN
|
$20M |
| 4 |
RYZB
RayzeBio, Inc. Common Stock
RYZB
|
$18.4M |
| 5 |
GSK
GSK
|
$12.4M |
Top Sells
| 1 |
TG Therapeutics
TGTX
|
$38.2M |
| 2 |
Arcellx
ACLX
|
$26.9M |
| 3 |
Insulet
PODD
|
$20.4M |
| 4 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$20.3M |
| 5 |
Evolus
EOLS
|
$19M |
Sector Composition
| 1 | Healthcare | 99.95% |
| 2 | Consumer Staples | 0.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Natera
NTRA
$23B
| – | – |
-61,377
| Closed | -$2.72M |
|
102
BioLife Solutions
BLFS
$1.2B
| – | – |
-439,000
| Closed | -$6.06M |
|
103
Design Therapeutics
DSGN
$339M
| – | – |
-1,025,000
| Closed | -$2.42M |
|
|
104
Evolus
EOLS
$477M
| – | – |
-2,078,000
| Closed | -$19M |
|
105
89bio
ETNB
$1.37B
| – | – |
-346,033
| Closed | -$5.34M |
|
|
106
Insulet
PODD
$24.2B
| – | – |
-127,680
| Closed | -$20.4M |
|
107
Praxis Precision Medicines
PRAX
$980M
| – | – |
-76,667
| Closed | -$1.97M |
|